Randomized Study of Darbepoetin Alfa and Recombinant Human Erythropoietin for Treatment of Renal Anemia in Chronic Renal Failure Patients Receiving Peritoneal Dialysis

Randomized Study of Darbepoetin Alfa and Recombinant Human Erythropoietin for Treatment of Renal Anemia in Chronic Renal Failure Patients Receiving Peritoneal Dialysis

Darbepoetin alfa can be administered less frequently than recombinant human erythropoietin (r-HuEPO) for the treatment of anemia in chronic renal failure (CRF) patients. We aimed to confirm that darbepoetin alfa at a reduced dosing schedule can safely maintain a target hemoglobin level in CRF patien...

Full description

Bibliographic Details
Main Authors: Wen-Yi Li, Tzong-Shinn Chu, Jenq-Wen Huang, Ming-Shiou Wu, Kwan-Dun Wu
Format: Article
Language:English
Published: Elsevier 2008-11-01
Series:Journal of the Formosan Medical Association
Subjects:
anemia
chronic renal failure
darbepoetin alfa
erythropoietin
peritoneal dialysis
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664608602004

Internet

http://www.sciencedirect.com/science/article/pii/S0929664608602004

Similar Items